-
1
-
-
0031784438
-
Combined therapy with deferiprone and desferrioxamine
-
Wonke B, Wright C, Hoffbrand AV. Combined therapy with deferiprone and desferrioxamine. Br J Haematol 1998; 103(2):361-364.
-
(1998)
Br J Haematol
, vol.103
, Issue.2
, pp. 361-364
-
-
Wonke, B.1
Wright, C.2
Hoffbrand, A.V.3
-
2
-
-
0242584372
-
Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients
-
Mourad FH, Hoffbrand AV, Sheikh-Taha M, Koussa S, Khoriaty AI, Taher A. Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients. Br J Haematol 2003; 121(1):187-189.
-
(2003)
Br J Haematol
, vol.121
, Issue.1
, pp. 187-189
-
-
Mourad, F.H.1
Hoffbrand, A.V.2
Sheikh-Taha, M.3
Koussa, S.4
Khoriaty, A.I.5
Taher, A.6
-
3
-
-
0032514558
-
Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major
-
Olivieri NF, Brittenham GM, McLaren CE, Templeton DM, Cameron RG, McClelland RA, Burt AD, Fleming KA. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med 1998; 339(7):417-423.
-
(1998)
N Engl J Med
, vol.339
, Issue.7
, pp. 417-423
-
-
Olivieri, N.F.1
Brittenham, G.M.2
McLaren, C.E.3
Templeton, D.M.4
Cameron, R.G.5
McClelland, R.A.6
Burt, A.D.7
Fleming, K.A.8
-
4
-
-
0042943205
-
Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone
-
Cohen AR, Galanello R, Piga A, De Sanctis V, Tricta F. Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone. Blood 2003; 102(5):1583-1587.
-
(2003)
Blood
, vol.102
, Issue.5
, pp. 1583-1587
-
-
Cohen, A.R.1
Galanello, R.2
Piga, A.3
De Sanctis, V.4
Tricta, F.5
-
5
-
-
0031985039
-
Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients
-
Hoffbrand AV, AL-Refaie F, Davis B, Siritanakatkul N, Jackson BF, Cochrane J, Prescott E, Wonke B. Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients. Blood 1998; 91(1):295-300.
-
(1998)
Blood
, vol.91
, Issue.1
, pp. 295-300
-
-
Hoffbrand, A.V.1
Al-Refaie, F.2
Davis, B.3
Siritanakatkul, N.4
Jackson, B.F.5
Cochrane, J.6
Prescott, E.7
Wonke, B.8
-
6
-
-
0034094839
-
Safety profile of the oral iron chelator deferiprone: A multicentre study
-
Cohen AR, Galanello R, Piga A, Dipalma A, Vullo C, Tricta F. Safety profile of the oral iron chelator deferiprone: a multicentre study. Br J Haematol 2000; 108(2):305-312.
-
(2000)
Br J Haematol
, vol.108
, Issue.2
, pp. 305-312
-
-
Cohen, A.R.1
Galanello, R.2
Piga, A.3
Dipalma, A.4
Vullo, C.5
Tricta, F.6
-
7
-
-
0032887235
-
Deferiprone: A review of its clinical potential in iron overload in β-thalassaemia major and other transfusion-dependent diseases
-
Barman Balfour JA, Foster RH. Deferiprone: a review of its clinical potential in iron overload in β-thalassaemia major and other transfusion-dependent diseases. Drugs 1999; 58(3):553-578.
-
(1999)
Drugs
, vol.58
, Issue.3
, pp. 553-578
-
-
Barman Balfour, J.A.1
Foster, R.H.2
-
8
-
-
0037630378
-
Role of deferiprone in chelation therapy for transfusional iron overload
-
Hoffbrand AV, Cohen A, Hershko C. Role of deferiprone in chelation therapy for transfusional iron overload. Blood 2003; 102(1):17-24.
-
(2003)
Blood
, vol.102
, Issue.1
, pp. 17-24
-
-
Hoffbrand, A.V.1
Cohen, A.2
Hershko, C.3
-
9
-
-
0036721452
-
Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent β-thalassemia
-
Wanless IR, Sweeney G, Dhillon AP, Guido M, Piga A, Galanello R, Gamberini MR, Schwartz E, Cohen AR. Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent β-thalassemia. Blood 2002; 100(5):1566-1569.
-
(2002)
Blood
, vol.100
, Issue.5
, pp. 1566-1569
-
-
Wanless, I.R.1
Sweeney, G.2
Dhillon, A.P.3
Guido, M.4
Piga, A.5
Galanello, R.6
Gamberini, M.R.7
Schwartz, E.8
Cohen, A.R.9
-
10
-
-
0033693878
-
Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)
-
Kontoghiorghes GJ, Pattichi K, Hadjigavriel M, Kolnagou A. Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1). Transfus Sci 2000; 23(3):211-223.
-
(2000)
Transfus Sci
, vol.23
, Issue.3
, pp. 211-223
-
-
Kontoghiorghes, G.J.1
Pattichi, K.2
Hadjigavriel, M.3
Kolnagou, A.4
-
11
-
-
3042777499
-
Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with β-thalassemia major
-
Wu KH, Chang JS, Tsai CH, Peng CT. Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with β-thalassemia major. Ann Hematol 2004; 83(7):471-473.
-
(2004)
Ann Hematol
, vol.83
, Issue.7
, pp. 471-473
-
-
Wu, K.H.1
Chang, J.S.2
Tsai, C.H.3
Peng, C.T.4
|